150 related articles for article (PubMed ID: 1693056)
1. 3'-Azido-3'-deoxythymidine prevents induction of murine acquired immunodeficiency syndrome in C57BL/10 mice infected with LP-BM5 murine leukemia viruses, a possible animal model for antiretroviral drug screening.
Ohnota H; Okada Y; Ushijima H; Kitamura T; Komuro K; Mizuochi T
Antimicrob Agents Chemother; 1990 Apr; 34(4):605-9. PubMed ID: 1693056
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
Nakashima H; Matsui T; Harada S; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024
[TBL] [Abstract][Full Text] [Related]
3. Zidovudine (AZT) reduces virus titer, retards immune dysfunction, and prolongs survival in the LP-BM5 murine induced immunodeficiency model.
Basham T; Rios CD; Holdener T; Merigan TC
J Infect Dis; 1990 May; 161(5):1006-9. PubMed ID: 2157768
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS.
Green KA; Noelle RJ; Green WR
Virology; 1998 Feb; 241(2):260-8. PubMed ID: 9499800
[TBL] [Abstract][Full Text] [Related]
6. High frequency of transmission of murine AIDS virus in C57BL/10 mice via mother's milk.
Okada Y; Suzuki K; Komuro K; Mizuochi T
J Virol; 1992 Sep; 66(9):5177-82. PubMed ID: 1323688
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclophosphamide, total body irradiation, and zidovudine on retrovirus proliferation and disease progression in murine AIDS.
Klinman DM; Krieg A; Conover J; Ussery MA; Black PL
AIDS Res Hum Retroviruses; 1992 Jan; 8(1):101-6. PubMed ID: 1310603
[TBL] [Abstract][Full Text] [Related]
8. Effect of selenium supplementation on mice infected with LP-BM5 MuLV, a murine AIDS model.
Chen C; Zhou J; Xu H; Jiang Y; Zhu G
Biol Trace Elem Res; 1997; 59(1-3):187-93. PubMed ID: 9522061
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency.
Green KA; Noelle RJ; Durell BG; Green WR
J Virol; 2001 Apr; 75(8):3581-9. PubMed ID: 11264347
[TBL] [Abstract][Full Text] [Related]
10. Effects of LP-BM5 murine leukemia virus infection on errors and response time in a two-choice serial reaction time task in C57BL/6 mice.
Lee B; Tumu P; Paul IA
Brain Res; 2002 Sep; 948(1-2):1-7. PubMed ID: 12383949
[TBL] [Abstract][Full Text] [Related]
11. Dissociation between lymphoproliferative responses and virus replication in mice with different sensitivities to retrovirus-induced immunodeficiency.
Pozsgay JM; Reid S; Pitha PM
J Virol; 1993 Feb; 67(2):980-8. PubMed ID: 8380473
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of murine retrovirus-induced acquired immunodeficiency by CD4 T regulatory cell depletion and PD-1 blockade.
Li W; Green WR
J Virol; 2011 Dec; 85(24):13342-53. PubMed ID: 21917983
[TBL] [Abstract][Full Text] [Related]
13. 3'-Azido-3'-deoxythymidine ameliorates the thrombocytopenia observed in a murine model of AIDS.
Chow FP; Sutton PA; Hamburger AW
Exp Hematol; 1990 Oct; 18(9):1038-41. PubMed ID: 2168839
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of LP-BM5 murine leukemia retrovirus RNA using real-time RT-PCR.
Cook WJ; Green KA; Obar JJ; Green WR
J Virol Methods; 2003 Mar; 108(1):49-58. PubMed ID: 12565153
[TBL] [Abstract][Full Text] [Related]
15. Accelerated progression of a murine retrovirus-induced immunodeficiency syndrome in Fas mutant C57BL/6 lpr/lpr mice.
Hiromatsu K; Usami J; Aoki Y; Makino M; Yoshikai Y
Microbiol Immunol; 1997; 41(3):221-7. PubMed ID: 9130234
[TBL] [Abstract][Full Text] [Related]
16. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens.
Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H
Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315
[TBL] [Abstract][Full Text] [Related]
17. Intermittent, alternating, and concurrent regimens of zidovudine and 2'-3' dideoxycytidine in the LP-BM5 murine induced immunodeficiency model.
Basham T; Holdener T; Merigan T
J Infect Dis; 1991 Apr; 163(4):869-72. PubMed ID: 1849164
[TBL] [Abstract][Full Text] [Related]
18. Effects of exogenous, nonleukemogenic, ecotropic murine leukemia virus infections on the immune systems of adult C57BL/6 mice.
Lee JS; Giese NA; Elkins KL; Yetter RA; Holmes KL; Hartley JW; Morse HC
J Virol; 1995 Jul; 69(7):4182-8. PubMed ID: 7769677
[TBL] [Abstract][Full Text] [Related]
19. Failure of stem cell factor to ameliorate AZT-induced anemia in immunodeficient mice.
Hamburger AW; Zsebo K; Chow FP
Eur J Haematol; 1993 Mar; 50(3):172-8. PubMed ID: 7682517
[TBL] [Abstract][Full Text] [Related]
20. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
Chow FP; Zsebo K; Hamburger AW
Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
